No-one is likely to forget the tragic events of 2020 and one company leading efforts to prepare for the next pandemic is Poolbeg Pharma. Optimum Strategic Communications’ Richard Staines interviewed CEO Jeremy Skillington to find the latest insights. Discussions are not about whether another pandemic will happen, but when, as a number of factors converge […]
Investment firms Medicxi has raised $400M for Medicxi IV Fund Markus Kalousek and Andrew Lightfoot have joined BGV as Venture Partner André Leue has joined Bell Rock Capital Management LLP as Portfolio Manager Global Equities Healthcare Evan Castiglia has joined Thuja Healthcare Investors as an Investment Director and Partner Analysts and Banking Dominic Wilson has […]
A much-anticipated new potential drug for COPD moved a step closer to the market after Verona Pharma submitted its New Drug Application to the U.S. FDA, seeking approval of ensifentrine as a maintenance therapy. In the latest episode of Optimum Perspectives podcast, Eva Haas caught up with Chris Martin, Senior Vice President of Commercial, who […]
Is a world without disease possible? That was the question posed by a meeting held at The Royal Society of Medicine in London last month. I hate to be a killjoy – but the answer is ‘No’. A world without disease would be a world without death. I’m sure the organisers of the The World […]
One Nucleus’ On Helix Conference 2023, provided insight into the current climate for Biotech companies, including the international outlook, and what to expect in the future. The past few years have been tough for the international Biotech market, with funding, Brexit, new regulations, trade agreements and supply chain issues. Additionally, valuations have fallen and consequently […]
